Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts

Journal of the American College of Surgeons

Volumn 218, Issue 4, 2014, Pages 608-617

  Yip Schneider, Michele T ^a   Wu, Huangbing ^a   Dumas, Ryan P ^a   Hancock, Brad A ^a   Agaram, Narasimhan ^a   Radovich, Milan ^a   Schmidt, C Max ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUCINOUS CYSTIC NEOPLASM; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSEUDOCYST; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREAS; PANCREATECTOMY; PANCREATIC CYST; PANCREATIC NEOPLASMS; PANCREATIC PSEUDOCYST; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84896489275     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2013.12.019     Document Type: Article

References (29)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. F. Harinck, J.W. Poley, and I. Kluijt et al. Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer Dig Dis 28 2010 670 678
3. M.B. Pitman, K. Lewandrowski, and J. Shen et al. Pancreatic cysts: preoperative diagnosis and clinical management Cancer Cytopathol 118 2010 1 13
4. M.K. Sheehan, K. Beck, J. Pickleman, and G.V. Aranha Spectrum of cystic neoplasms of the pancreas and their surgical management Arch Surg 138 2003 657 660 discussion 660-662
5. W.R. Brugge, K. Lewandrowski, and E. Lee-Lewandrowski et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study Gastroenterology 126 2004 1330 1336
6. J.L. Frossard, P. Amouyal, and G. Amouyal et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions Am J Gastroenterol 98 2003 1516 1524
7. R.S. Kwon, and D.M. Simeone The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas Int J Proteomics 2011 2011 413646
8. M. Pelaez-Luna, S.T. Chari, and T.C. Smyrk et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients Am J Gastroenterol 102 2007 1759 1764
9. J.R. Rodriguez, R. Salvia, and S. Crippa et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection Gastroenterology 133 2007 72 79
10. R. Salvia, S. Crippa, and M. Falconi et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56 2007 1086 1090
11. R.S. Tang, B. Weinberg, and D.W. Dawson et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm Clin Gastroenterol Hepatol 6 2008 815 819
12. S. Tanno, Y. Nakano, and T. Nishikawa et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results Gut 2008 57
13. W.G. Park Screening for pancreatic cancer: what can cyst fluid analysis tell us? F1000 Med Rep 3 2011 3
14. A. Khalid, M. Zahid, and S.D. Finkelstein et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study Gastrointest Endosc 69 2009 1095 1102
15. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
16. P. Hammel, P. Levy, and H. Voitot et al. Preoperative cyst fluid analysis is useful for the differential-diagnosis of cystic lesions of the pancreas Gastroenterology 108 1995 1230 1235
17. A. Rapisarda, and G. Melillo Role of the VEGF/VEGFR axis in cancer biology and therapy Adv Cancer Res 114 2012 237 267
18. B. Sitohy, J.A. Nagy, and H.F. Dvorak Anti-VEGF/VEGFR therapy for cancer: reassessing the target Cancer Res 72 2012 1909 1914
19. D. Thirabanjasak, O. Basturk, and D. Altinel et al. Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis? Pancreatology 9 2009 182 188
20. K. Sato, M. Miyakawa, and N. Onoda et al. Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules J Clin Endocrinol Metab 82 1997 1968 1973
21. R.E. Banks, P. Tirukonda, and C. Taylor et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer Cancer Res 66 2006 2000 2011
22. V.H. Mohr, A.O. Vortmeyer, and Z. Zhuang et al. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients Am J Pathol 157 2000 1615 1621
23. M. Ivan, and W.G. Kaelin Jr. The von Hippel-Lindau tumor suppressor protein Curr Opin Genet Dev 11 2001 27 34
24. J. Wu, Y. Jiao, and M. Dal Molin et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways Proc Natl Acad Sci U S A 108 2011 21188 21193
25. N. Ferrara Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action Mol Biol Cell 21 2010 687 690
26. C.J. Doyle, N.P. Agaram, M.T. Yip-Schneider, and C.M. Schmidt Transforming growth factor alpha levels in pancreatic fluid Pancreas 40 2011 260 264
27. B.B. Haab, A. Porter, and T. Yue et al. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms Ann Surg 251 2010 937 945
28. C.M. Schmidt, M.T. Yip-Schneider, and M.C. Ralstin et al. PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia J Gastrointest Surg 12 2008 243 249
29. J. Wu, H. Matthaei, and A. Maitra et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development Sci Transl Med 3 2011 92ra66